Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.595 AUD | -2.46% | -7.03% | +11.21% |
05-15 | Recce Pharmaceuticals Doses First Patient in Urosepsis Rapid Infusion Clinical Trial | MT |
05-10 | Recce Pharmaceuticals Finds 'Promising' Results From Nebulized RECCE 327 Pilot Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.21% | 83.09M | |
+32.36% | 694B | |
+30.00% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.45% | 239B | |
+10.43% | 209B | |
-3.15% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- RCE Stock
- News Recce Pharmaceuticals Ltd
- Recce Pharmaceuticals Secures AU$47.8 Million Advanced Overseas Finding Award from AusIndustry